Work

SF3B4 promotes gastric cancer progression through CPNE1 splicing-mediated regulation of MAPK and p53 signaling

Year: 2026
Type: article
Abstract: Gastric cancer (GC) is a heterogeneous malignancy with poor clinical outcomes. Aberrant alternative splicing contributes to tumor progression; however, its regulation in GC remains incompletely understood. Here, we identify Splicing factor 3b subunit 4 (SF3B4) as a pro-tumorigenic splicing factor in GC. SF3B4 was found to be upregulated and associated with unfavorable prognosis. Depleting SF3B4 inhibited GC cell proliferation, migration, invasion, and xenograft growth, whereas overexpressing it enhanced these malignant phenotypes. SF3B4 depletion also activated DNA damage-associated p53/p21 signaling and induced G2/M phase arrest, apoptosis, and a senescence-associated phenotype. Mechanistically, SF3B4 physically associated with copine 1 (CPNE1) pre-mRNA and promoted exon 5 inclusion, thereby maintaining the full-length CPNE1 isoform (CPNE1-L). Functional and molecular rescue assays showed that CPNE1-L reversed the effects of SF3B4 depletion significantly more effectively than the exon 5-skipped CPNE1 isoform (CPNE1-S), both in vitro and in xenografts. The SF3B4-CPNE1-L axis sustained MAPK/ERK activation, while trametinib attenuated both the malignant phenotypes enhanced by SF3B4 overexpression and the rescue effects of CPNE1-L. Collectively, these findings identify CPNE1 exon 5 inclusion as a mechanism through which SF3B4 contributes to GC progression, linking CPNE1 splicing to sustained MAPK/ERK signaling and attenuated p53/p21 responses associated with DNA damage.
Language: English
Open Access status: gold
Estimated APC paid: $4,290
OpenAlex ID: W7237090337
FWCI:
Cites:
Cited by:
Related to: 10